Search results for “HLA-DQ” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 26 patents, we discovered top 10 key players by total patent application. Wakunaga Pharmaceutical Co., Ltd., Japanese Red Cross Society, Selecta Biosciences, Inc. are dominant in this area. They take 73.08% of the total patent filing.
Wakunaga Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 7
Japanese Red Cross Society
Tokyo-to, Japan
Patent: 7
Selecta Biosciences, Inc.
Massachusetts, United States
Patent: 5
Peptimmune, Inc.
Massachusetts, United States
Patent: 4
bioMérieux SA
France
Patent: 2
Japan Health Sciences Foundation
Japan
Patent: 2
F. Hoffmann-La Roche Ltd.
Switzerland
Patent: 1
Meiji Co., Ltd.
Tokyo-to, Japan
Patent: 1
CBR, Inc.
Minnesota, United States
Patent: 1
Changsha Sanji Biotech Co. Ltd.
Hunan Sheng, China
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 16 patents, we discovered top 3 universities and scientific research institutions by total patent application.
President & Fellows of Harvard College
Massachusetts, United States
Patent: 5
Kanazawa University
Ishikawa-ken, Japan
Patent: 3
University of Tsukuba
Osaka-fu, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: